A REVIEW OF CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT

Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors from the central anxious process, conolidine modulates alternate molecular targets. A Science Innovations study identified that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7,